AYTU BIOPHARMA INC (AYTU) Stock News

USA - NASDAQ:AYTU - US0547548588 - Common Stock

2.13 USD

+0.03 (+1.43%)

Last: 11/12/2025, 11:24:21 AM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AYTU Latest News, Press Relases and Analysis

All

Press Releases

3 hours ago - By: Zacks Investment Research - Mentions: ATXS

Astria Therapeutics, Inc. (ATXS) Reports Q3 Loss, Misses Revenue Estimates

6 days ago - By: Zacks Investment Research - Mentions: ETON

Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates

7 days ago - By: ACCESS Newswire

Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025

15 days ago - By: ACCESS Newswire

Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)

a month ago - By: Zacks Investment Research - Mentions: ALK CNM

New Strong Sell Stocks for Oct. 13th

2 months ago - By: ACCESS Newswire

Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)

2 months ago - By: Benzinga - Mentions: AIR AZO MU WOR ...

Earnings Scheduled For September 23, 2025

2 months ago - By: Benzinga

Earnings Outlook For Aytu BioPharma

5 months ago - By: ACCESS Newswire

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)

a month ago - By: ACCESS Newswire

Aytu BioPharma to Present at Upcoming October 2025 Conferences

2 months ago - By: ACCESS Newswire - Mentions: LCUT NTRB GEVO XHLD ...

11 Company Presentations Today at The MicroCap Rodeo Conference

2 months ago - By: ACCESS Newswire

Aytu BioPharma to Present at Upcoming September 2025 Conferences

5 months ago - By: ACCESS Newswire

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

2 months ago - By: Stocktwits - Mentions: SPY QQQ DJI SPX ...

News Image

Dow Futures Gain Ahead Of Jerome Powell’s Speech: BA, HOLO, BETR, CLSK Among Stocks To Watch

2 months ago - By: ACCESS Newswire

Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025

3 months ago - By: Zacks Investment Research - Mentions: A

Agilent Technologies (A) Surpasses Q3 Earnings and Revenue Estimates

4 months ago - By: Yahoo Finance - Mentions: NVDA

Lake Street Sees Big Upside for Aytu Biosciences (AYTU) After EXXUA Acquisition

4 months ago - By: Yahoo Finance

Aytu Boosts Liquidity with Eclipse Loan Extension

5 months ago - By: ACCESS Newswire

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

5 months ago - By: ACCESS Newswire

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

5 months ago - By: Yahoo Finance

Aytu BioPharma to commercialise Exxua for MDD in the US

5 months ago - By: ACCESS Newswire

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States